Literature DB >> 28302949

Isolated and Combined Valve Surgery in Elderly Patients: A Comparison of Mid-Term Results.

Fumiya Yoneyama1, Chiho Tokunaga1, Yoshiharu Enomoto1, Kisato Mitomi1, Hiroaki Sakamoto1, Yuji Hiramatsu1.   

Abstract

BACKGROUND: This study examined mid-term outcomes of valve surgery in the elderly, and focused on the difference in outcomes between isolated and combined valve surgery.
METHODS: From January 2012 to June 2016, 113 consecutive patients aged 75 years and older underwent valve surgery. In all, 60 underwent isolated valve surgery (Group I), and 53 underwent combined valve surgery (Group C) involving the combination of any valve procedures or valve surgery with concurrent other procedure. Short- and mid-term outcomes were compared between the two groups.
RESULTS: There was no significant difference in length of intensive care unit stay (2.8 days in Group S vs. 4.2 days in Group C, p = 0.08), hospital stay (16.2 vs. 18.7 days, p = 0.22), and mechanical ventilation (11.2 vs. 15.0 hours, p = 0.28). Neither was there any significant difference in operative mortality (1.6% vs. 5.6%, p = 0.25) nor morbidity (8.3% vs. 9.4%, p = 0.83) between the two groups. Actuarial survival rates at 1 and 3 years were 98.3% in Group S and 92.0% in Group C (log-rank p = 0.126).
CONCLUSION: Once patients have tolerated combined surgery during the early postoperative period, good survival rates equaling those of isolated valve surgery can be expected.

Entities:  

Keywords:  combined valve surgery; elderly patients; isolated valve surgery

Mesh:

Year:  2017        PMID: 28302949      PMCID: PMC5483858          DOI: 10.5761/atcs.oa.16-00303

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  9 in total

1.  Outcomes of cardiac surgery in patients > or = 80 years: results from the National Cardiovascular Network.

Authors:  K P Alexander; K J Anstrom; L H Muhlbaier; R D Grosswald; P K Smith; R H Jones; E D Peterson
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

2.  Is an age of 80 years or greater an important predictor of short-term outcomes of isolated aortic valve replacement in veterans?

Authors:  Faisal G Bakaeen; Danny Chu; Joseph Huh; Blase A Carabello
Journal:  Ann Thorac Surg       Date:  2010-09       Impact factor: 4.330

3.  Twenty years of cardiac surgery in patients aged 80 years and older: risks and benefits.

Authors:  Markus Krane; Bernhard Voss; Andreas Hiebinger; Marcus Andre Deutsch; Michael Wottke; Alexander Hapfelmeier; Catalin C Badiu; Robert Bauernschmitt; Rüdiger Lange
Journal:  Ann Thorac Surg       Date:  2011-02       Impact factor: 4.330

4.  Outcomes and cost of cardiac surgery in octogenarians is related to type of operation: a multiinstitutional analysis.

Authors:  Castigliano M Bhamidipati; Damien J LaPar; Edwin Fonner; John A Kern; Irving L Kron; Gorav Ailawadi
Journal:  Ann Thorac Surg       Date:  2011-02       Impact factor: 4.330

5.  Feasibility and efficacy of mitral valve repair for degenerative mitral regurgitation in the elderly.

Authors:  Takashi Murashita; Yukikatsu Okada; Hideo Kanemitsu; Naoto Fukunaga; Yasunobu Konishi; Ken Nakamura; Tadaaki Koyama
Journal:  Ann Thorac Cardiovasc Surg       Date:  2014-01-15       Impact factor: 1.520

6.  Is mitral valve repair superior to replacement in elderly patients?

Authors:  Gorav Ailawadi; Brian R Swenson; Micah E Girotti; Leo M Gazoni; Benjamin B Peeler; John A Kern; Lynn M Fedoruk; Irving L Kron
Journal:  Ann Thorac Surg       Date:  2008-07       Impact factor: 4.330

7.  Aortic valve replacement in octogenarians: risk factors for early and late mortality.

Authors:  Spencer J Melby; Andreas Zierer; Scott P Kaiser; Tracey J Guthrie; Jason D Keune; Richard B Schuessler; Michael K Pasque; Jennifer S Lawton; Nader Moazami; Marc R Moon; Ralph J Damiano
Journal:  Ann Thorac Surg       Date:  2007-05       Impact factor: 4.330

8.  Activation of the lectin pathway of complement by cardiopulmonary bypass contributes to the development of systemic inflammatory response syndrome after paediatric cardiac surgery.

Authors:  I Pągowska-Klimek; A S Świerzko; M Michalski; E Głowacka; A Szala-Poździej; A Sokołowska; M Moll; W R Krajewski; J Romak; M Cedzyński
Journal:  Clin Exp Immunol       Date:  2016-02-08       Impact factor: 4.330

9.  Effects of cardiopulmonary bypass on lung nuclear factor-kappa B activity, cytokine release, and pulmonary function in dogs.

Authors:  Gaisheng Yang; Xiaodong Xue; Yanying Chen; Zhihong Song; Zhen Jiang; Kejian Hu
Journal:  Iran J Basic Med Sci       Date:  2015-12       Impact factor: 2.699

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.